Last reviewed · How we verify
Lactobacillus rhamnosus GG and Bifidobacterium lactis BB12
Lactobacillus rhamnosus GG and Bifidobacterium lactis BB12 is a Small molecule drug developed by Medical University of Warsaw. It is currently FDA-approved. Also known as: Probiotics.
At a glance
| Generic name | Lactobacillus rhamnosus GG and Bifidobacterium lactis BB12 |
|---|---|
| Also known as | Probiotics |
| Sponsor | Medical University of Warsaw |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- A Probiotic Intervention to Prevent Relapse Following Hospitalization for Mania (PHASE3)
- Respiratory Tract Microbiome and Probiotics in Children With Cleft Palate (NA)
- Prevention of Irinotecan Induced Diarrhea by Probiotics (PHASE3)
- Effect of Probiotics on Nasopharyngeal Microbiome of Children With Otitis Media With Effusion (NA)
- Prevention of Febrile Neutropenia by Synbiotics in Pediatric Cancer Patients (PHASE2)
- Probiotics and Early Microbial Contact in Preterm Neonates (NA)
- The Effect of Probiotics in HIV-1 Infection (NA)
- Probiotics in Newly Recognized Type 1 Diabetes (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Lactobacillus rhamnosus GG and Bifidobacterium lactis BB12 CI brief — competitive landscape report
- Lactobacillus rhamnosus GG and Bifidobacterium lactis BB12 updates RSS · CI watch RSS
- Medical University of Warsaw portfolio CI
Frequently asked questions about Lactobacillus rhamnosus GG and Bifidobacterium lactis BB12
What is Lactobacillus rhamnosus GG and Bifidobacterium lactis BB12?
Lactobacillus rhamnosus GG and Bifidobacterium lactis BB12 is a Small molecule drug developed by Medical University of Warsaw.
Who makes Lactobacillus rhamnosus GG and Bifidobacterium lactis BB12?
Lactobacillus rhamnosus GG and Bifidobacterium lactis BB12 is developed and marketed by Medical University of Warsaw (see full Medical University of Warsaw pipeline at /company/medical-university-of-warsaw).
Is Lactobacillus rhamnosus GG and Bifidobacterium lactis BB12 also known as anything else?
Lactobacillus rhamnosus GG and Bifidobacterium lactis BB12 is also known as Probiotics.
What development phase is Lactobacillus rhamnosus GG and Bifidobacterium lactis BB12 in?
Lactobacillus rhamnosus GG and Bifidobacterium lactis BB12 is FDA-approved (marketed).
Related
- Manufacturer: Medical University of Warsaw — full pipeline
- Also known as: Probiotics
- Compare: Lactobacillus rhamnosus GG and Bifidobacterium lactis BB12 vs similar drugs
- Pricing: Lactobacillus rhamnosus GG and Bifidobacterium lactis BB12 cost, discount & access